0 CHECKOUT

PRODUCT FILTERS

REGION

11,361
8,384
8,322
7,692
7,644

COUNTRY

7,261
1,184
495
454
375

CATEGORIES

  • 2,890
  • 2,498
  • 2,032
  • 1,864
  • 1,785
  • 1,696
    • 314
    • 245
    • 234
    • 234
    • 211
    • 170
    • 161
    • 161
    • 140
    • 137
    • 135
    • 127
    • 80
    • 74
    • 42
  • 1,256
  • 1,238
  • 1,172
  • 966
    • 146
  • 923
  • 908
  • 816
  • 502
  • 414
  • 402
  • 376
    • 394
      • 57
    • 113
  • 370
  • 370
  • 238
    • 609
    • 86
    • 52
  • 155
  • 129
SHOW ALL

PRICE

4,465
7,668
14,218
31,238

PUBLISHED

2,483
6,649
14,595
31,238

PRODUCT TYPE

24,184
3,059
2,689
724
295
114
66
46
33
20
6
1
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. Show Less Read more

Ionotropic Glutamate Receptor Antagonists -Pipeline Insights, 2016

SUMMARY The report, “Ionotropic Glutamate Receptor Antagonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Ionotropic Glutamate...

Published:  March 2016
Price:  From

Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2016

SUMMARY The report, “Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around...

Published:  March 2016
Price:  From

Vascular Adhesion Protein 1 (VAP-1) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Vascular Adhesion Protein 1 (VAP-1) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Vascular Adhesion...

Published:  March 2016
Price:  From

Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Type...

Published:  March 2016
Price:  From

Transforming Growth Factor Alpha (TGFa) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Transforming Growth Factor Alpha (TGFa) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Transforming...

Published:  March 2016
Price:  From

Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities...

Published:  March 2016
Price:  From

Sigma 1 Receptor Agonists -Pipeline Insights, 2016

SUMMARY The report, “Sigma 1 Receptor Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Sigma 1 Receptor Agonists. The...

Published:  March 2016
Price:  From

Serotonin-Norepinephrine Reuptake Inhibitors(SNRI) -Pipeline Insights, 2016

SUMMARY The report, “Serotonin-Norepinephrine Reuptake Inhibitors(SNRI)-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Serotonin-Norepinephrine...

Published:  March 2016
Price:  From

Serotonin Transporter Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Serotonin Transporter Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Serotonin Transporter Inhibitors....

Published:  March 2016
Price:  From

Serotonin Reuptake Inhibitors (SRI) -Pipeline Insights, 2016

SUMMARY The report, “Serotonin Reuptake Inhibitors (SRI)-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Serotonin Reuptake Inhibitors...

Published:  March 2016
Price:  From

Serotonin (5-HT) Receptor Antagonists -Pipeline Insights, 2016

SUMMARY The report, “Serotonin (5-HT) Receptor Antagonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Serotonin (5-HT) Receptor...

Published:  March 2016
Price:  From

Serotonin (5-HT) Receptor Agonists -Pipeline Insights, 2016

SUMMARY The report, “Serotonin (5-HT) Receptor Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Serotonin (5-HT) Receptor...

Published:  March 2016
Price:  From

Transforming Growth Factor Beta (TGFb) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Transforming Growth Factor Beta (TGFb) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Transforming...

Published:  March 2016
Price:  From

Transcription Factor Activator Protein-1 (AP-1) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Transcription Factor Activator Protein-1 (AP-1) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the...

Published:  March 2016
Price:  From

PBP1A Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “PBP1A Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the PBP1A Inhibitors. The report covers the...

Published:  March 2016
Price:  From

Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors(SNDRI) -Pipeline Insights, 2016

SUMMARY The report, “Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors(SNDRI)-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around...

Published:  March 2016
Price:  From

Motilin Receptor Agonists -Pipeline Insights, 2016

SUMMARY The report, “Motilin Receptor Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Motilin Receptor Agonists. The...

Published:  March 2016
Price:  From

Mitochondrial Electron Transport Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Mitochondrial Electron Transport Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Mitochondrial...

Published:  March 2016
Price:  From

Interleukin-17 (IL-17) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Interleukin-17 (IL-17) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Interleukin-17 (IL-17)...

Published:  March 2016
Price:  From

Interleukin-16 (IL-16) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Interleukin-16 (IL-16) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Interleukin-16 (IL-16)...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients